Overview
Peter Martin is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Follicular Lymphoma, Mantle Cell Lymphoma (MCL), Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.
His clinical research consists of co-authoring 71 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
525 E 68th St, New York, NY 10065
506 6th St, Brooklyn, NY 11215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Weill Medical College Of Cornell
John Allan is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Allan has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Splenectomy.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Martin isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Martin isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Martin isDistinguished. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Martin isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Lymphofollicular HyperplasiaDr. Martin isDistinguished. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Dr. Martin isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- B-Cell LymphomaDr. Martin isAdvanced. Learn about B-Cell Lymphoma.
- Chronic Lymphocytic Leukemia (CLL)
- Classical Hodgkin LymphomaDr. Martin isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Gastric LymphomaDr. Martin isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Martin isAdvanced. Learn about Hodgkin Lymphoma.
- Multiple MyelomaDr. Martin isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Adult Immune ThrombocytopeniaDr. Martin isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Martin isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Martin isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Autoimmune Hemolytic AnemiaDr. Martin isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Bone Marrow AspirationDr. Martin isExperienced. Learn about Bone Marrow Aspiration.
- Chronic Familial NeutropeniaDr. Martin isExperienced. Learn about Chronic Familial Neutropenia.